Concepedia

Author

Helle Linnebjerg

Eli Lilly (United States)ORCID

Also Known As

H LINNEBJERG, H Linnebjerg, H. Linnebjerg, H.-Y. Gao, HELLE LINNEBJERG, Helle LINNEBJERG, Helle Linnebjerg

78

Publications

2.3K

Citations

26

H-Index

31

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (United Kingdom)Clinical Nutrition Research CentreProfil Institute for Metabolic ResearchEli Lilly (Singapore)
HL

About

Helle Linnebjerg is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

605

2

Health Sciences

1

1

255

3

Allergy

1

1

13

4

Biochemistry

1

1

68

5

Biomolecular Engineering

1

1

11

Helle Linnebjerg

×

34

Publications

2.1K

Citations

24

H-Index

YearCitations

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

Helle Linnebjerg, Soomin Park, Prajakti A. Kothare,

Regulatory Peptides

2008

255

Effect of renal impairment on the pharmacokinetics of exenatide

Helle Linnebjerg, Prajakti A. Kothare, Soomin Park,

British Journal of Clinical Pharmacology

2007

198

Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)

Steven E. Nissen, Helle Linnebjerg, Xi Shen,

JAMA

2023

172

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

Stephen J. Nicholls, Steven E. Nissen, Cynthia Griggs Fleming,

JAMA

2023

161

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

Amparo de la Peña, Matthew C. Riddle, Linda Morrow,

Diabetes Care

2011

121

The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations

Ole Thastrup, Helle Linnebjerg, Poul Jannik Bjerrum,

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

1987

100

Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies

Helle Linnebjerg, Eric Chen Quin Lam, Mary Seger,

Diabetes Care

2015

95

Effect of Exenatide on the Steady‐State Pharmacokinetics of Digoxin

Prajakti A. Kothare, Danny Soon, Helle Linnebjerg,

The Journal of Clinical Pharmacology

2005

68

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL

Amparo de la Peña, Mary Seger, Danny Soon,

Clinical Pharmacology in Drug Development

2015

68

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

Tim Heise, Helle Linnebjerg, David E. Coutant,

Diabetes Obesity and Metabolism

2020

63

Page 1